全文获取类型
收费全文 | 46141篇 |
免费 | 3334篇 |
国内免费 | 2912篇 |
专业分类
耳鼻咽喉 | 231篇 |
儿科学 | 778篇 |
妇产科学 | 343篇 |
基础医学 | 3043篇 |
口腔科学 | 269篇 |
临床医学 | 5576篇 |
内科学 | 4397篇 |
皮肤病学 | 1107篇 |
神经病学 | 1013篇 |
特种医学 | 968篇 |
外国民族医学 | 34篇 |
外科学 | 2234篇 |
综合类 | 12924篇 |
预防医学 | 4065篇 |
眼科学 | 702篇 |
药学 | 7741篇 |
72篇 | |
中国医学 | 4921篇 |
肿瘤学 | 1969篇 |
出版年
2024年 | 571篇 |
2023年 | 1813篇 |
2022年 | 2048篇 |
2021年 | 2334篇 |
2020年 | 1809篇 |
2019年 | 1728篇 |
2018年 | 953篇 |
2017年 | 1471篇 |
2016年 | 1607篇 |
2015年 | 1743篇 |
2014年 | 2238篇 |
2013年 | 2181篇 |
2012年 | 2810篇 |
2011年 | 3084篇 |
2010年 | 2955篇 |
2009年 | 2648篇 |
2008年 | 2588篇 |
2007年 | 2277篇 |
2006年 | 2210篇 |
2005年 | 2108篇 |
2004年 | 1718篇 |
2003年 | 1633篇 |
2002年 | 1370篇 |
2001年 | 1214篇 |
2000年 | 880篇 |
1999年 | 707篇 |
1998年 | 586篇 |
1997年 | 550篇 |
1996年 | 523篇 |
1995年 | 414篇 |
1994年 | 384篇 |
1993年 | 277篇 |
1992年 | 221篇 |
1991年 | 189篇 |
1990年 | 216篇 |
1989年 | 157篇 |
1988年 | 60篇 |
1987年 | 41篇 |
1986年 | 45篇 |
1985年 | 18篇 |
1984年 | 5篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1976年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
132.
蜂毒生物制品及其临床应用价值 总被引:2,自引:0,他引:2
中国蜂毒的应用研究比国外发展快,目前已经制成的蜂毒生物制品包括蜂针、蜂毒注射液和精制蜂毒注射液。蜂毒制品临床上主要用于治疗风湿性关节炎和类风湿性关节炎,其疗效优于蝎毒和其他药物,被认为是目前治疗风湿和类风湿关节炎最好的药物。其它的疗效还有治疗神经痛和高血压等。本文首先对蜂毒中的生理活性成份进行了叙述,综述了近年来国内外以蜂毒为原料生物制药的现状。对蜂毒生物药品的种类和临床应用进行了重点论述,认为蜂毒生物制药的前景光明.并指出目前蜂毒生物制药存在的问题。 相似文献
133.
多年以来 ,临床上发现肾综合征出血热 (HFRS)患者常出现血糖升高 ,并有患者因出现非酮性高渗性昏迷[1 ,2 ] 。因此 ,HFRS患者糖代谢紊乱应予以重视 ,为了对 HFRS患者糖代谢紊乱进一步探索 ,本人对 HFRS患者空腹血糖 (FBG)及糖化血红蛋白 (GHb)水平进行了动态观察 ,现报告如下。1 对象和方法1.1 对象 HFRS4 3例 ,分别于极期、恢复期、痊愈后 3个月进行了检测 ,其中男 38例 ,女 6例 ,年龄 12~ 6 3岁 ,平均 35 .5岁 ,全部病例按卫生部 1987年 EHF防治方案进行分型 ,且 EL ISA检测 EHF特异性抗体阳性。对照组 2 0例为健康体… 相似文献
134.
纤维蛋白原检测的指南 总被引:3,自引:0,他引:3
英国血液学界通常通过纤维蛋白原的测定来判断纤维蛋白量的降低和质的异常,评估出血危险性。纤维蛋白原的升高通常预示各种缺血性事件的存在,建议进行纤维蛋白原检测就是基于这种观点。 相似文献
135.
Objective To investigate whether low-protein diet has protective effect on the progression of renal interstitial fibrosis in rats with cyclosporine A (CsA)-induced nephropathy. Methods Eighteen male Sprague-Dawley rats were randomly divided into three groups (6 rats in each group). The rats in control group (C group) received common diet; in model group (M group) low-salt diet; in intervention group (Ⅰ group) low-salt and low-protein diet. After diet adaptation period of one week, the rats in C group received subcutaneous injection of olive oil 1 mg/kg daily for 5 weeks, while M group and Ⅰ group subcutaneous injection of CsA (diluted into 25 g/L with olive oil) 1 ml/kg for 5 weeks. All the rats were sacrificed at the end of the 5th week. The food-intake and body weight were measured daily. The creatinine clearance (Ccr) was examined before rats were sacrificed. The semi-quantitative pathological analysis on kidney sections was performed. The mRNA and protein expression of transforming growth factor-β1 (TGF-βI) and type Ⅰ collagen (Col Ⅰ) in kidney tissue was determined with real time PCR and immunohistochemical staining, respectively. Results The food-intake and body weight of rats in M and I groups were significantly lower than those in C group (P<0.05). Compared with C group, the Ccr levels in M and Ⅰ groups were significantly reduced [(0.65±0.15) ml/min, (0.40+0.13) ml/min vs (1.55±0.29) ml/min, P<0.05], the relative fibrosis areas of kidney interstitium in M and I groups were significantly increased (3.60%±0.46%, 3.26%±0.75% vs 0.44%±0.24%, P<0.05), the mRNA and protein expression of TGF-β1 in M and I group was significantly up-regulated (by 2.6 and 3.1 times in mRNA and by 1.5 and 1.6 times in protein, respectively, P<0.05), and the mRNA and protein expression of Col Ⅰ in M and I groups was also significantly up-regulated (by 3.0 and 3.5 times in mRNA and by 2.3 and 2.1 times in protein, respectively, P<0.05). There were no significant differences between M and I groups in every parameters above-mentioned except the rat body weight and Ccr. Both the body weight and Ccr in Ⅰ group were significantly lower than those in M group (P<0.05). Compared with C group, the urine osmotic pressure in M group and in I group were deceased (for M group, P>0.05; for I group, P<0.05). Compared with C group, the serum cholesterol levels in M and I groups were significantly increased (P<0.05), and the serum phosphorus level in I group was significantly decreased (P<0.05). The levels of serum albumin and serum calcium of all three groups had no statistical differences (P>0.05). Conclusion Low-protein diet has no renoprutective effects on the rat model of cyclosporin A nephropathy, on the contrary, may induce body weight loss. 相似文献
136.
雷帕霉素对炎性反应状态下肾小球系膜细胞内脂质稳态的影响 总被引:2,自引:1,他引:1
Objective To investigate the effect of rapamycin on cholesterol homeostasis of glomerular mesangial cells and the underlying mechanism. Methods Glomerular mesangial cell line (HMCL) cells were cultured and divided into control group, IL-1β group and different concentration rapamycin groups. Intracellular cholesterol accumulation was observed and measured by oil O staining and HPLC. Real-time quantitative PCR and Western blot were used to detect the mRNA and protein expression of LDLR, PPARγ, LXRα, ABCA1 in HMCL after the treatment with IL-1β and rapamycin. Results Rapamycin had no significant influence on intracellular cholesterol concentration under normal condition. IL-1β significantly increased the intracellular cholesterol concentration by 143% of control (P<0.05), and 10, 50, 100 ?滋g/L rapamycin could significantly inhibit the effect of IL-1β (87%, 116%, 96% of control respectively, all P<0.05). Rapamycin could suppress the increased expression of LDLR caused by IL-1β on both mRNA and protein level in a dose-dependent manner(P<0.01). Rapamycin dose-dependently up-regulated the reduced mRNA and protein expression of ABCA1, the decreased mRNA expression of PPARγ and LXRα induced by IL-1β as well (P<0.01). Conclusion Rapamycin may contribute to the maintenance of intracellular cholesterol homeostasis in glomerular mesangial cells under inflammatory state by both reducing cholesterol uptake and promoting cholesterol efflux. 相似文献
137.
F-Z液与HC-A液对内皮细胞保存效果的比较研究 总被引:1,自引:0,他引:1
HC-A液(高渗枸橼酸盐腺嘌呤液)是由第二军医大学附属长征医院(何长民等)与上海市中心血站(刘书元等)在Ross溶液基础上加以改良而成,经过约20年的肾移植临床应用,获得广泛的肯定。但HC-A液对于肝脏、胰腺和心脏的保存效果较差,不能满足临床需要,因此,笔者对其进行改进,并取得了较好的结果,命名为F-Z液,下文就是在内皮细胞水平,对两者的保存效果进行比较的结果。[第一段] 相似文献
138.
HLA-DRB1*1501等位基因与环孢菌素A治疗再生障碍性贫血疗效的关系 总被引:3,自引:1,他引:2
近年来日本学者发现日本的再生障碍性贫血(AA)患者HLA—DRB1 *1501等位基因的频率较普通人群高,对环孢菌素A(CSA)治疗敏感且具有依赖性。由于HIA各等位基因存在较大的种族和地域差异,在汉族人群中是否可以据此预测CsA对AA的疗效,目前报道较少。我们用PCR-SSO及PCR-SSP技术检测山东日照地区汉族AA患者中该等位基因,观察其与CsA疗效的关系。 相似文献
139.
阿维A胶囊联合银屑灵片治疗寻常性银屑病的临床观察 总被引:2,自引:0,他引:2
目的探讨银屑灵片联合阿维A胶囊治疗瘀滞肌肤型寻常性(斑块状)银屑病的疗效及安全性。方法采用随机单盲对照(1:1)试验方法将98例患者分为两组。治疗组口服阿维A胶囊、银屑灵片;对照组口服阿维A胶囊,于治疗前后分别评定PASI积分。结果①两组治疗后PASI积分降低,治疗前后积分差异有显著性(P<0.05)。②治疗组痊愈32例(68.08%),显效9例(19.15%),好转4例(8.51%),无效2例(4.20%);对照组分别为23例(51.11%)、8例(17.78%)、7例(15.56%)和7例(15.56%),两组疗效差异有显著性(P<0.05);两组意图治疗分析(intention-to-treatanalysis)差异也有显著性(P<0.05)。结论阿维A胶囊结合银屑灵片治疗瘀滞肌肤型寻常性(斑块状)银屑病疗效及安全性优于对照组。 相似文献
140.